Superior Alternatives: Single-Agent GLP-1 Therapy Modern precision weight loss medicine has moved beyond combining multiple medications toward optimizing single agents through personalized dosing and genetic insights
International Archives of Allergy and Immunology, 136 (2), 155-158
"But studies have found that a BMI higher than 25 increases ones risk for heart disease, type two diabetes, and some forms of cancer
Our providers are trained in wellness optimization and focus on building thoughtful, ongoing care plans that evolve with you over time
Because Farxiga is in the same drug class as Jardiance, side effects are similar
These studies used longer-acting GLP-1 drugs, which Gloyn said may help overcome some aspects of the resistance